The Venture Codex Logo

The Venture Codex

Amplifica

3525 Del Mar Heights Rd Ste A583, San Diego, CA, 92130, United States

Overview

Amplifica is a preclinical stage biopharmaceutical company focused on developing novel treatments to address androgenic alopecia.

Total investments
3
Lead investments
1
Investments · 12mo
2
Active investors
3

Sector focus

  • Biopharma
  • Clinical Trials
Visit website

Investment portfolio

  • Pitz

    Participated · Seed · May 2026

    Pitz offers a specialized operating platform for automotive repair shops that centralizes diagnostics, administration, parts procurement and logistics. Its technology includes an AI-powered virtual assistant that converts voice-described faults into repair plans and a marketplace with more than one million SKUs for parts sourcing. The company serves over 1,400 connected workshops and aims to reach more than 8,000 by 2026. Pitz has prioritized Brazil as its main growth market, establishing a fully local team there, and is preparing a formal entry into the United States targeting Latino independent auto communities. The startup will use the recent funding to bolster its AI capabilities and accelerate regional and U.S. expansion. The company was founded by Natália Salcedo, a former Rappi and Jokr executive.

  • Retorna

    Participated · Equity · Jun 2024

    Retorna is a Chilean fintech founded in 2018 by Atilana Piñón and Juan Camilo Mora that facilitates cross-border remittances for migrants with easy, fast and secure transactions and fair fees. The company’s core product simplifies money transfers between countries and targets financial inclusion for migrant populations across the region. Until this raise the startup was fully bootstrapped, and the new capital marks its first external funding round. Retorna plans to use the funds to scale customer acquisition and retention efforts and to open new remittance corridors connecting the region. The team emphasizes social impact and economic empowerment of migrants as central to its product and go-to-market strategy. Participation in Impacta VC’s fundraising programs in 2023 helped prepare the company for this fundraise and validated the team’s capacity to scale.

Team

  • Maksim Plikus

    Co-Founder and Chief Scientific Officer

    LinkedIn
  • William Rassman

    Co-Founder and Chief Medical Officer

  • Wajdie Ahmad

    Co-Founder, Executive Chairman and COO

    LinkedIn